End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45.61 CNY | +2.96% | +9.43% | +0.84% |
Apr. 26 | Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3% | MT |
Apr. 17 | Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ETFs positioned on Jiangsu Hengrui Medicine Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.18% | 2 M€ | -16.59% | - | |
3.73% | 2 M€ | -14.14% | ||
1.74% | 1 M€ | -9.86% | - | |
1.18% | 96 M€ | -1.45% | ||
0.51% | 35 M€ | -5.85% | - | |
0.27% | 4 M€ | -11.56% | ||
0.15% | 11 M€ | +1.79% | ||
0.07% | 1 M€ | +3.49% | - | |
0.07% | 3 M€ | -.--% | - | |
0.03% | 441 M€ | +4.60% | - | |
0.03% | 2,808 M€ | +5.90% | - | |
0.03% | 149 M€ | +2.17% | - | |
0.03% | 117 M€ | +1.11% | - | |
0.03% | 4 M€ | -4.41% | - | |
0.01% | 31 M€ | +3.50% | - | |
0.00% | 7 M€ | +1.95% | - | |
0.00% | 34 M€ | +2.14% | - | |
0.00% | 389 M€ | +6.83% | - | |
0.00% | 34 M€ | +6.71% | - | |
0.00% | 147 M€ | +4.88% | - | |
0.00% | 39 M€ | +3.67% | - | |
0.00% | 302 M€ | +3.80% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.84% | 40.02B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 600276 Stock
- Funds and ETFs Jiangsu Hengrui Medicine Co., Ltd.